147 related articles for article (PubMed ID: 17459445)
1. Inhibition of human immunodeficiency virus type 1 transcription by N-aminoimidazole derivatives.
Stevens M; Balzarini J; Lagoja IM; Noppen B; François K; Van Aerschot A; Herdewijn P; De Clercq E; Pannecouque C
Virology; 2007 Aug; 365(1):220-37. PubMed ID: 17459445
[TBL] [Abstract][Full Text] [Related]
2. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37.
Okamoto H; Cujec TP; Okamoto M; Peterlin BM; Baba M; Okamoto T
Virology; 2000 Jul; 272(2):402-8. PubMed ID: 10873784
[TBL] [Abstract][Full Text] [Related]
5. The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA.
Zhou M; Deng L; Kashanchi F; Brady JN; Shatkin AJ; Kumar A
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12666-71. PubMed ID: 14569024
[TBL] [Abstract][Full Text] [Related]
6. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
Van Lint C; Quivy V; Demonté D; Chariot A; Vanhulle C; de Walque S; Gaudray G; Veithen E; Bours V; Piette J; Burny A
Bull Mem Acad R Med Belg; 2004; 159(Pt 2):176-89. PubMed ID: 15615091
[TBL] [Abstract][Full Text] [Related]
8. Recent status of HIV-1 gene expression inhibitors.
Baba M
Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
[TBL] [Abstract][Full Text] [Related]
9. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.
Lusic M; Marcello A; Cereseto A; Giacca M
EMBO J; 2003 Dec; 22(24):6550-61. PubMed ID: 14657027
[TBL] [Abstract][Full Text] [Related]
11. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
12. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.
Abbott KL; Archambault J; Xiao H; Nguyen BD; Roeder RG; Greenblatt J; Omichinski JG; Legault P
Biochemistry; 2005 Mar; 44(8):2716-31. PubMed ID: 15723517
[TBL] [Abstract][Full Text] [Related]
13. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
[TBL] [Abstract][Full Text] [Related]
14. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
Chipitsyna G; Sawaya BE; Khalili K; Amini S
J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter.
Thierry S; Marechal V; Rosenzwajg M; Sabbah M; Redeuilh G; Nicolas JC; Gozlan J
J Virol; 2004 Nov; 78(22):12198-206. PubMed ID: 15507606
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.
Baba M; Okamoto M; Kawamura M; Makino M; Higashida T; Takashi T; Kimura Y; Ikeuchi T; Tetsuka T; Okamoto T
Mol Pharmacol; 1998 Jun; 53(6):1097-103. PubMed ID: 9614214
[TBL] [Abstract][Full Text] [Related]
17. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication.
Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O
J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells.
Sarol LC; Imai K; Asamitsu K; Tetsuka T; Barzaga NG; Okamoto T
Biochem Biophys Res Commun; 2002 Mar; 291(4):890-6. PubMed ID: 11866448
[TBL] [Abstract][Full Text] [Related]
19. 4-Phenylcoumarins as HIV transcription inhibitors.
Bedoya LM; Beltrán M; Sancho R; Olmedo DA; Sánchez-Palomino S; del Olmo E; López-Pérez JL; Muñoz E; San Feliciano A; Alcamí J
Bioorg Med Chem Lett; 2005 Oct; 15(20):4447-50. PubMed ID: 16137881
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
Dreikhausen U; Hiebenthal-Millow K; Bartels M; Resch K; Nourbakhsh M
Mol Cell Biol; 2005 Sep; 25(17):7473-83. PubMed ID: 16107696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
